One example is better access to affordable essential drugs for developing countries, as foreseen in the Millennium Development Goals. Switzerland, with its major pharmaceutical industry and long humanitarian tradition, is committed both to adequate protection of intellectual property as well as access to essential drugs for the world’s poorest countries. It should be mentioned that that the private sector is becoming increasingly aware of its social and global responsibilities in the field of health, and this development will present new opportunities for cooperation.